| __timestamp | Insmed Incorporated | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 33534999 | 21226345 |
| Thursday, January 1, 2015 | 1982000 | 139626 |
| Friday, January 1, 2016 | 2438000 | 93831530 |
| Sunday, January 1, 2017 | 2901000 | 79419009 |
| Monday, January 1, 2018 | 2423000 | 368673 |
| Tuesday, January 1, 2019 | 24212000 | 477121 |
| Wednesday, January 1, 2020 | 39872000 | 1895029 |
| Friday, January 1, 2021 | 44152000 | 8034589 |
| Saturday, January 1, 2022 | 55126000 | 20443000 |
| Sunday, January 1, 2023 | 65573000 | 33745000 |
Unleashing the power of data
In the ever-evolving world of biotechnology, understanding the financial landscape is crucial. This analysis delves into the cost structures of Intra-Cellular Therapies, Inc. and Insmed Incorporated from 2014 to 2023. Over this decade, Insmed Incorporated's cost of revenue surged by approximately 95%, peaking in 2023. In contrast, Intra-Cellular Therapies, Inc. experienced a more volatile trajectory, with a significant spike in 2016, where costs increased by over 400% compared to the previous year. This fluctuation highlights the dynamic nature of the biotech industry, where research and development investments can lead to substantial cost variations. As these companies continue to innovate, understanding their financial strategies provides valuable insights into their growth and sustainability. This data not only reflects past trends but also offers a glimpse into the future of biotech financial management.
Cost of Revenue Comparison: Sanofi vs Intra-Cellular Therapies, Inc.
Cost of Revenue Trends: Vertex Pharmaceuticals Incorporated vs Insmed Incorporated
Cost of Revenue Trends: Biogen Inc. vs Insmed Incorporated
Intra-Cellular Therapies, Inc. vs Sarepta Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Intra-Cellular Therapies, Inc. vs MorphoSys AG: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs HUTCHMED (China) Limited
Intra-Cellular Therapies, Inc. vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Insmed Incorporated vs Walgreens Boots Alliance, Inc.
Insmed Incorporated vs Exelixis, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Insmed Incorporated and Telix Pharmaceuticals Limited
Cost of Revenue: Key Insights for Insmed Incorporated and Ionis Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Bausch Health Companies Inc.